01/30/2023
https://congress.gov...
"The bacterium's resistance to colistin is particularly concerning because in this country physicians use colistin as the treatment of last resort."
"We need a full panoply of investment in the research, the basic science, the drug discovery and drug development that lasts."
"I want to talk about how we can incentivize development of new antibiotics."
"opening statement"